KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sarepta Therapeutics (SRPT) Inventory Average: 2016-2025

Historic Inventory Average for Sarepta Therapeutics (SRPT) over the last 9 years, with Sep 2025 value amounting to $1.0 billion.

  • Sarepta Therapeutics' Inventory Average rose 96.93% to $1.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 billion, marking a year-over-year increase of 96.93%. This contributed to the annual value of $536.4 million for FY2024, which is 103.64% up from last year.
  • According to the latest figures from Q3 2025, Sarepta Therapeutics' Inventory Average is $1.0 billion, which was up 7.01% from $967.7 million recorded in Q2 2025.
  • Over the past 5 years, Sarepta Therapeutics' Inventory Average peaked at $1.0 billion during Q3 2025, and registered a low of $192.6 million during Q1 2022.
  • Over the past 3 years, Sarepta Therapeutics' median Inventory Average value was $429.7 million (recorded in 2024), while the average stood at $522.5 million.
  • As far as peak fluctuations go, Sarepta Therapeutics' Inventory Average dropped by 22.96% in 2022, and later surged by 142.88% in 2025.
  • Sarepta Therapeutics' Inventory Average (Quarterly) stood at $237.3 million in 2021, then dropped by 10.43% to $212.6 million in 2022, then skyrocketed by 33.33% to $283.4 million in 2023, then spiked by 132.13% to $657.9 million in 2024, then soared by 96.93% to $1.0 billion in 2025.
  • Its Inventory Average was $1.0 billion in Q3 2025, compared to $967.7 million in Q2 2025 and $845.7 million in Q1 2025.